Tularemia vaccine development: paralysis or progress?
نویسندگان
چکیده
منابع مشابه
Pain education and training: progress or paralysis?
The time has come for organized medicine, led by the American Academy of Pain Medicine (AAPM) working with other pain organizations, to address systematically and rigorously the need for standards in pain education for all medical schools and relevant training in pain management for all clinical specialties. This education and training needs to be provided by faculty uniformly and reliably trai...
متن کاملCurrent status of vaccine development for tularemia preparedness
Tularemia is a high-risk infectious disease caused by Gram-negative bacterium Francisella tularensis. Due to its high fatality at very low colony-forming units (less than 10), F. tularensis is considered as a powerful potential bioterrorism agent. Vaccine could be the most efficient way to prevent the citizen from infection of F. tularensis when the bioterrorism happens, but officially approved...
متن کاملProgress in HIV vaccine development.
Recent advances in HIV vaccine development include initiation of the first efficacy trials and substantial expansion of the preclinical pipeline. Several preclinical candidate vaccines have induced strong cellular immune responses and provided impressive protection against AIDS in non-human primate models; however, candidates that induce broadly neutralizing antibodies remain elusive.
متن کاملUpdate on progress in HIV vaccine development.
The 19th Conference on Retroviruses and Opportunistic Infections heralded the arrival of a new crop of potent, broadly neutralizing antibodies against HIV. This advance has given the entire vaccine field enormous hope that it will be possible one day to develop an antibody-based vaccine for HIV. However, substantial obstacles still exist in the induction of these antibodies by vaccination, give...
متن کاملProgress and challenges in TB vaccine development
The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB) disease, and although imperfect, BCG is proof that vaccine mediated protection against TB is a possibility. A new TB vaccine is, therefore, an inevitability; the question is how long will it take us to get there? We have made substantial progress in the development of vaccine platforms, in the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccine: Development and Therapy
سال: 2016
ISSN: 2230-2298
DOI: 10.2147/vdt.s85545